1. A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects. (1st December 2020) Authors: Farmahini Farahani, Mohammad; Maghzi, Parnian; Jafari Aryan, Nazanin; Payandemehr, Borna; Soni, Mayur; Azhdarzadeh, Morteza Journal: Expert opinion on investigational drugs Issue: Volume 29:Number 12(2020) Page Start: 1443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗